Lisa Weyandt

Dr. Lisa Weyandt


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2013 in Journal of Psychopathology and Behavioral Assessment
Verified
Journal Article
Closed access
PDF file
LWLisa Weyandt
Lisa Weyandt
GDGeorge J. DuPaul
George J. DuPaul
GVGenevieve Verdi
Genevieve Verdi
JRJoseph S. Rossi
Joseph S. Rossi
ASAnthony J. Swentosky
Anthony J. Swentosky
KCKristen S. Carson
Kristen S. Carson

1 January 2008 in Developmental Disabilities Research Reviews
Verified
Journal Article
Closed access
PDF file
LWLisa Weyandt
Lisa Weyandt
GDGeorge J. DuPaul
George J. DuPaul

1 October 2016 in Experimental and Clinical Psychopharmacology
Verified
Journal Article
Open access
LWLisa Weyandt
Lisa Weyandt
DODanielle R. Oster
Danielle R. Oster
MMMarisa E. Marraccini
Marisa E. Marraccini
BGBergljot Gyda Gudmundsdottir
Bergljot Gyda Gudmundsdottir
BMBailey A. Munro
Bailey A. Munro
AMAlison McCallum
Alison McCallum
Prescription stimulants, including methylphenidate (e.g., Ritalin) and amphetamine compounds (e.g., dextroamphetamine; Adderall), have been approved by the U.S. Food and Drug Administration for the treatment of attention-deficit/hyperactivity disorder (ADHD) and are classified by the United States Drug Enforcement Administration as Schedule II medications because of their high potential for abuse and dependence (Drug Enforcement Administration, U.S. Department of Justice, 2015). Despite the potential health and judicial consequences, misuse of prescription stimulants, typically defined as taking stimulants without a valid prescription, or use of stimulants other than as prescribed, has become a serious problem in the United States and abroad, especially on college campuses. The purpose of the present article is to review historical information concerning prescription stimulants and to summarize the literature with respect to misuse among adults, particularly college students, including risk factors, mediators and moderators, and motivations for prescription stimulant misuse. In addition, evidence is presented concerning the question of whether prescription stimulants truly enhance cognitive functioning in individuals with and without ADHD, and the ethical and professional implications of these findings are explored. Lastly, recommendations for addressing prescription stimulant misuse and suggestions for future research are advanced. (PsycINFO Database Record

17 May 2013 in Developmental Neuropsychology
Verified
Journal Article
Closed access
LWLisa Weyandt
Lisa Weyandt
ASAnthony Swentosky
Anthony Swentosky
BGBergljot Gyda Gudmundsdottir
Bergljot Gyda Gudmundsdottir
Attention deficit hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by pervasive and developmentally inappropriate levels of inattention, impulsivity, and hyperactivity. There is no conclusive cause of ADHD although a number of etiologic theories have been advanced. Research across neuroanatomical, neurochemical, and genetic disciplines collectively support a physiological basis for ADHD and, within the past decade, the number of neuroimaging studies concerning ADHD has increased exponentially. The current selective review summarizes research findings concerning ADHD using functional magnetic resonance imaging (fMRI), positron emission tomography (PET), and diffusion tensor imaging (DTI). Although these technologies and studies offer promise in helping to better understand the physiologic underpinnings of ADHD, they are not without methodological problems, including inadequate sensitivity and specificity for psychiatric disorders. Consequently, neuroimaging technology, in its current state of development, should not be used to inform clinical practice.

27 June 2018 in Pharmacy
Verified
Journal Article
Open access
PDF file
LWLisa Weyandt
Lisa Weyandt
TWTara L. White
Tara L. White
BGBergljot Gyda Gudmundsdottir
Bergljot Gyda Gudmundsdottir
ANAdam Z. Nitenson
Adam Z. Nitenson
EREmma S. Rathkey
Emma S. Rathkey
SBStephanie A. Bjorn
Stephanie A. Bjorn
Prescription stimulant medications are considered a safe and long-term effective treatment for Attention Deficit Hyperactivity Disorder (ADHD). Studies support that stimulants enhance attention, memory, self-regulation and executive function in individuals with ADHD. Recent research, however, has found that many college students without ADHD report misusing prescription stimulants, primarily to enhance their cognitive abilities. This practice raises the question whether stimulants actually enhance cognitive functioning in college students without ADHD. We investigated the effects of mixed-salts amphetamine (i.e., Adderall, 30 mg) on cognitive, autonomic and emotional functioning in a pilot sample of healthy college students without ADHD (n = 13), using a double-blind, placebo-controlled, within-subjects design. The present study was the first to explore cognitive effects in conjunction with mood, autonomic effects, and self-perceptions of cognitive enhancement. Results revealed that Adderall had minimal, but mixed, effects on cognitive processes relevant to neurocognitive enhancement (small effects), and substantial effects on autonomic responses, subjective drug experiences, and positive states of activated emotion (large effects). Overall, the present findings indicate dissociation between the effects of Adderall on activation and neurocognition, and more importantly, contrary to common belief, Adderall had little impact on neurocognitive performance in healthy college students. Given the pilot design of the study and small sample size these findings should be interpreted cautiously. The results have implications for future studies and the education of healthy college students and adults who commonly use Adderall to enhance neurocognition.

11 August 2020 in Journal of American College Health
Verified
Journal Article
Closed access
LWLisa Weyandt
Lisa Weyandt
BGBergljot Gyda Gudmundsdottir
Bergljot Gyda Gudmundsdottir
EHEmily Z. Holding
Emily Z. Holding
MMMarisa E Marraccini
Marisa E Marraccini
MKMegan Keith
Megan Keith
CSCaroline Sweeney
Caroline Sweeney
Misuse of prescription opioids has substantially increased in the past decade among the general population, including among university students. Relative to the literature concerning opioid misuse among the general population, little information is available regarding the college student population. Objective: The purpose of the present study was to conduct a systematic review of the literature concerning the prevalence of prescription opioid misuse among the university student population. Results: The lifetime estimate for prescription opioid misuse among general populations of students ranged from 4% to 19.7%, with higher estimates for special student populations. Students most at risk for misuse of prescription opioids are those who report higher rates of psychological distress, depression, and suicidal thoughts and behaviors, and white, male students who use alcohol and illicit drugs. Conclusions: Findings from this study underscore the need for opioid prevention and intervention programs on university campuses.